Enhanced Paveway™ PLUS Selects Expression Organisms Based on Titer Plus Quality

This comprehensive white paper unveils a revolutionary approach to selecting expression organisms based on both titer and product quality. Learn how our advanced workflow enables rapid evaluation and precise protein characterization, addressing challenges in detecting post-translational modifications early in the process. Explore how Paveway™ PLUS optimizes strain selection, expression systems, and purification methods, providing actionable insights in just eleven weeks. Dive into a detailed case study featuring Designed Ankyrin Repeat Proteins (DARPins) and see firsthand the advantages of this enhanced technology. Ideal for researchers and developers focused on innovative drug discovery and development, this guide provides critical data to propel your projects forward.